These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 465894)

  • 1. Backward walking and circling: behavioural responses induced by drug treatments which cause simultaneous release of catecholamines and 5-hydroxytryptamine.
    Curzon G; Fernando JC; Lees AJ
    Br J Pharmacol; 1979 Aug; 66(4):573-9. PubMed ID: 465894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of d-fenfluramine and p-chloroamphetamine on H75/12-induced depletion of 5-hydroxytryptamine and dopamine in the rat brain.
    Fattaccini CM; Gozlan H; Hamon M
    Neuropharmacology; 1991 Jan; 30(1):15-23. PubMed ID: 1710793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of different amphetamines on copulatory behavior and stereotype activity in the female rat.
    Michanek A; Meyerson BJ
    Psychopharmacology (Berl); 1977 Jul; 53(2):175-83. PubMed ID: 408843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine and (+)-fenfluramine.
    Crespi D; Mennini T; Gobbi M
    Br J Pharmacol; 1997 Aug; 121(8):1735-43. PubMed ID: 9283711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperthermia induced by amphetamine, p-chloroamphetamine and fenfluramine in the rat-1.
    Frey H-H
    Pharmacology; 1975; 13(2):163-76. PubMed ID: 124876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioural responses to drugs releasing 5-hydroxytryptamine and catecholamines: effects of treatments altering precursor concentrations in brain.
    Fernando JC; Curzon G
    Neuropharmacology; 1981 Feb; 20(2):115-22. PubMed ID: 7207710
    [No Abstract]   [Full Text] [Related]  

  • 7. The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine.
    Berger UV; Gu XF; Azmitia EC
    Eur J Pharmacol; 1992 May; 215(2-3):153-60. PubMed ID: 1356787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p-Chloroamphetamine (PCA), 3,4-methylenedioxy-methamphetamine (MDMA) and d-fenfluramine pretreatment attenuates d-fenfluramine-evoked release of 5-HT in vivo.
    Series HG; Cowen PJ; Sharp T
    Psychopharmacology (Berl); 1994 Dec; 116(4):508-14. PubMed ID: 7535469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different action of 5-hydroxytryptamine (5-HT) uptake inhibitors on fenfluramine- but not p-chloramphetamine-induced hyperthermia in rats.
    Paełowski L
    J Pharm Pharmacol; 1981 Aug; 33(8):538-40. PubMed ID: 6115932
    [No Abstract]   [Full Text] [Related]  

  • 10. Some behavioural interactions between 5-hydroxytryptamine and dopamine.
    Curzon G
    Adv Exp Med Biol; 1981; 133():563-84. PubMed ID: 6459008
    [No Abstract]   [Full Text] [Related]  

  • 11. An in vivo dialysis and behavioural study of the release of 5-HT by p-chloroamphetamine in reserpine-treated rats.
    Adell A; Sarna GS; Hutson PH; Curzon G
    Br J Pharmacol; 1989 May; 97(1):206-12. PubMed ID: 2720308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence concerning the involvement of 5-hydroxytryptamine in the locomotor activity produced by amphetamine or tranylcypromine plus L-DOPA.
    Green AR; Kelly PH
    Br J Pharmacol; 1976 May; 57(1):141-7. PubMed ID: 1276533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central tryptaminergic mediation of the hyperthermia induced by amphetamine and halogenated analogues of it?
    Frey HH
    Pol J Pharmacol Pharm; 1975 Oct; 27(Suppl):89-90. PubMed ID: 128750
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of L-cysteine on the long-term depletion of brain indoles caused by p-chloroamphetamine and d-fenfluramine in rats. Relation to brain drug concentrations.
    Invernizzi R; Fracasso C; Caccia S; Di Clemente A; Garattini S; Samanin R
    Eur J Pharmacol; 1989 Apr; 163(1):77-83. PubMed ID: 2744095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin-lesion myoclonic syndromes. II. Analysis of individual syndrome elements, locomotor activity and behavioral correlations.
    Pranzatelli MR; Snodgrass SR
    Brain Res; 1986 Jan; 364(1):67-76. PubMed ID: 3484993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fenfluramine, p-chloroamphetamine and p-fluoroamphetamine stimulation of pituitary-adrenocortical activity in rat: evidence for differences in site and mechanism of action.
    McElroy JF; Miller JM; Meyer JS
    J Pharmacol Exp Ther; 1984 Mar; 228(3):593-9. PubMed ID: 6323674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous effects of p-chloroamphetamine, d-fenfluramine, and reserpine on free and stored 5-hydroxytryptamine in brain and blood.
    Martín F; Artigas F
    J Neurochem; 1992 Sep; 59(3):1138-44. PubMed ID: 1379630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coincidence of blockade of synaptosomal 5-hydroxytryptamine uptake and decrease in tryptophan hydroxylase activity: effects of fenfluramine.
    Knapp S; Mandell AJ
    J Pharmacol Exp Ther; 1976 Jul; 198(1):123-32. PubMed ID: 933002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of serotonin-releasing drugs on serum corticosterone concentration in rats.
    Fuller RW; Snoddy HD
    Neuroendocrinology; 1980 Aug; 31(2):96-100. PubMed ID: 6446690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of dopamine and 5-hydroxytryptamine in stereotyped and non-stereotyped behaviour.
    Dickinson SL; Curzon G
    Neuropharmacology; 1983 Jul; 22(7):805-12. PubMed ID: 6225959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.